• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Two leading Generali investors could seek new CEO -sources

September 11, 2021 by David Barret Leave a Comment

September 11, 2021

By Gianluca Semeraro and Claudia Cristoferi

MILAN (Reuters) -Two leading Generali investors are ready to push to replace current CEO Philippe Donnet if the top Italian insurer’s board fails to reach an accord to keep him in the job, three sources close to the matter said.

The Trieste-based insurer is due to appoint a new board next spring and speculation over Donnet’s future has mounted in recent months as tensions among shareholders simmer.

In a sign battle lines are being drawn, the two Generali investors, Francesco Gaetano Caltagirone and Leonardo Del Vecchio, on Saturday disclosed a pact to consult over decisions concerning Generali..

Donnet’s reappointment is in the hands of Generali’s board which for the first time can submit its own slate of board candidates after the insurer changed its by-laws last year.

The sources said the two businessmen, who struck the pact over a combined 10.95% stake, are ready to file their own list of board nominees. The list would not include the current CEO though he is willing to run for another mandate, they said.

Donnet is already working on a new business plan for Generali due in December after steering the company through the COVID-19 crisis and keeping it on track to fully meet goals under the current plan through to end-2021.

Donnet currently enjoys the backing of Alberto Nagel, the CEO of Milanese bank Mediobanca, which is Generali’s top investor with a 12.9% stake, as well as many board members at the insurer.

Del Vecchio and Caltagirone are also, respectively, the first- and second-biggest investor in Mediobanca.

Over the past year, however, both Caltagirone, whose businesses span construction to publishing, and Del Vecchio, the founder of Ray-Ban owner Luxottica, have been critical of Donnet’s strategy which they deem too cautious in seeking merger and acquisition opportunities.

According to one of the sources, the two businessmen could also propose a new chairman with a well-established international profile to oversee Generali’s growth strategies.

A compromise among shareholders is still possible, another of the sources said, and one solution could be the appointment of a managing director backed by both Del Vecchio and Caltagirone who would work alongside Donnet.

However, positions are still far apart, the sources said, ahead of a key meeting on Sept. 27 when Generali’s board will kick off proceedings to submit its own list of nominees.

Before that, in an apparent attempt to find common ground, Generali non-executive board members will meet on Sept. 14, a fourth source said. Donnet will not attend the meeting as he is an executive member, the source added.

(Reporting by Claudia Cristoferi and Gianluca Semeraro, editing by Valentina Za, Ros Russell and Christina Fincher)

Source Link Two leading Generali investors could seek new CEO -sources

David Barret
David Barret

Related posts:

  1. What 377 Y Combinator pitches will teach you about startups
  2. Tennis-Fearless teenagers and hungry qualifiers light up U.S. Open
  3. South Africa’s former President Zuma placed on medical parole
  4. Tennis-Qualifier Van de Zandschulp tames Argentine battler to reach quarters

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • People Are Only Now Learning Where The Titanic Actually Sank
  • A New Way Of Looking At Einstein’s Equations Could Reveal What Happened Before The Big Bang
  • First-Ever Look At Neanderthal Nasal Cavity Shatters Expectations, NASA Reveals Comet 3I/ATLAS Images From 8 Missions, And Much More This Week
  • The Latest Internet Debate: Is It More Efficient To Walk Around On Massive Stilts?
  • The Trump Administration Wants To Change The Endangered Species Act – Here’s What To Know
  • That Iconic Lion Roar? Turns Out, They Have A Whole Other One That We Never Knew About
  • What Are Gravity Assists And Why Do Spacecraft Use Them So Much?
  • In 2026, Unique Mission Will Try To Save A NASA Telescope Set To Uncontrollably Crash To Earth
  • Blue Origin Just Revealed Its Latest New Glenn Rocket And It’s As Tall As SpaceX’s Starship
  • What Exactly Is The “Man In The Moon”?
  • 45,000 Years Ago, These Neanderthals Cannibalized Women And Children From A Rival Group
  • “Parasocial” Announced As Word Of The Year 2025 – Does It Describe You? And Is It Even Healthy?
  • Why Do Crocodiles Not Eat Capybaras?
  • Not An Artist Impression – JWST’s Latest Image Both Wows And Solves Mystery Of Aging Star System
  • “We Were Genuinely Astonished”: Moss Spores Survive 9 Months In Space Before Successfully Reproducing Back On Earth
  • The US’s Surprisingly Recent Plan To Nuke The Moon In Search Of “Negative Mass”
  • 14,400-Year-Old Paw Prints Are World’s Oldest Evidence Of Humans Living Alongside Domesticated Dogs
  • The Tribe That Has Lived Deep Within The Grand Canyon For Over 1,000 Years
  • Finger Monkeys: The Smallest Monkeys In The World Are Tiny, Chatty, And Adorable
  • Atmospheric River Brings North America’s Driest Place 25 Percent Of Its Yearly Rainfall In A Single Day
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version